What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Disease
His main research concerns Type 1 diabetes, Immunology, Diabetes mellitus, Internal medicine and Autoantibody.
His research investigates the connection with Type 1 diabetes and areas like Genetic predisposition which intersect with concerns in HLA-DQ.
Immunology is frequently linked to Case-control study in his study.
His Diabetes mellitus research incorporates themes from Research design, Pediatrics, Breast feeding, Immunopathology and Risk factor.
His research in Internal medicine intersects with topics in Gastroenterology and Endocrinology.
His Autoantibody study introduces a deeper knowledge of Antibody.
His most cited work include:
- Prevalence of Celiac disease among children in Finland. (849 citations)
- The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes (570 citations)
- Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans (568 citations)
What are the main themes of his work throughout his whole career to date?
Mikael Knip mainly focuses on Type 1 diabetes, Internal medicine, Immunology, Diabetes mellitus and Endocrinology.
He has researched Type 1 diabetes in several fields, including Autoantibody, Human leukocyte antigen, Autoimmunity, Disease and Pediatrics.
His Autoantibody research is multidisciplinary, incorporating perspectives in Glutamate decarboxylase, Seroconversion and Antigen.
As a member of one scientific family, Mikael Knip mostly works in the field of Internal medicine, focusing on Offspring and, on occasion, Physiology.
Immunology is a component of his Antibody, Autoimmune disease, Enterovirus, Immunopathology and Immune system studies.
In his study, Allele is inextricably linked to Genotype, which falls within the broad field of Diabetes mellitus.
He most often published in these fields:
- Type 1 diabetes (62.04%)
- Internal medicine (46.34%)
- Immunology (47.53%)
What were the highlights of his more recent work (between 2015-2021)?
- Type 1 diabetes (62.04%)
- Immunology (47.53%)
- Autoimmunity (22.58%)
In recent papers he was focusing on the following fields of study:
Mikael Knip mainly investigates Type 1 diabetes, Immunology, Autoimmunity, Internal medicine and Autoantibody.
Type 1 diabetes is a subfield of Diabetes mellitus that Mikael Knip tackles.
His research investigates the connection between Diabetes mellitus and topics such as Pediatrics that intersect with issues in Cohort.
Mikael Knip combines subjects such as Microbiome and Haplotype with his study of Immunology.
His Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.
His studies in Autoantibody integrate themes in fields like Peripheral blood mononuclear cell, Family history and Lipidomics.
Between 2015 and 2021, his most popular works were:
- Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans (568 citations)
- Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability (437 citations)
- The role of the intestinal microbiota in type 1 diabetes mellitus (183 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Mikael Knip focuses on Type 1 diabetes, Immunology, Autoimmunity, Autoantibody and Internal medicine.
His Type 1 diabetes research is within the category of Diabetes mellitus.
The concepts of his Immunology study are interwoven with issues in Microbiome and Disease.
His Autoimmunity study combines topics from a wide range of disciplines, such as Prediabetes, Immunophenotyping, CXCR5, Innate immune system and Islet.
The various areas that Mikael Knip examines in his Autoantibody study include Peripheral blood cell and Lipidomics.
His Internal medicine research includes themes of Pregnancy, Endocrinology and Infant formula.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
